Palisade Bio
Price & Volume
Stats
See more52W Range | $0.88-$9.65 |
Market Cap | $2.6M |
Shares Short | 136,962 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$13.26 |
News
See moreYahoo Finance • 7 days ago
Palisade Bio, Inc. Announces Receipt of Cash Proceeds from Canada’s SR&ED Tax Incentive Program for Reimbursement of Development Costs of PALI-2108 for Treatment of Ulcerative Colitis (UC)
Yahoo Finance • 17 days ago
Palisade Bio Presents Positive Preclinical Data of PALI-2108 for the Treatment of Ulcerative Colitis
Yahoo Finance • 29 days ago
Palisade Bio Selected for Poster Presentation at the 2025 Crohn’s & Colitis Congress
Yahoo Finance • last year
Palisade Bio Reports Third Quarter 2023 Financial Results and Provides Business Outlook
About
CEO | Mr. J. D. Finley |
CFO | Mr. J. D. Finley |
Address | 7750 El Camino Real, Carlsbad, CA, United States, 92009 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 9 |
